Phenomenex is a technology company that pursues innovation. Since its establishment in 1982, we have been committed to researching new analytical chemistry solutions to address the separation and purification challenges faced by industrial, clinical, government, and academic researchers. Over the past forty years, Phenomenex has won the "R&D 100 Innovation Award" 11 times. Finomi's chromatographic solutions are driving the development of separation science, and as a local sub brand of Finomi, Aijer will work together with Finomi to provide researchers with the tools needed to improve global health and well-being.

Today, as a member of Danaher China Life Science Platform, we will continue to develop robust and reliable solutions in the field of chromatography technology to help rapidly transform emerging therapies and related drugs such as rare diseases, cancer, and vaccine biologics from drug discovery to clinical trial results. Provide higher standard analytical and testing methods in food testing, contact material testing, toxin testing, and environmental testing. Using the power of separation science to make human life better.